Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T10:01:59.001Z Has data issue: false hasContentIssue false
  • English
  • Français

Combined Antidepressant Therapy

Published online by Cambridge University Press:  29 January 2018

Frank Winston
Frank Winston*
Affiliation:
313 Price Place, Madison, Wisconsin, U.S.A. 53705
Get access Rights & Permissions [Opens in a new window]

Extract

It is still generally believed that it is dangerous to combine the tricyclic antidepressants with any of the M.A.O. inhibitors, and the Federal Drug Administration, the Witts Committee and the drug manufacturers caution against so doing. Several current texts reiterate these warnings. (Beck, 1967; Malitz, 1966: Shepherd et al., 1968).

Type
Research Article
Information
The British Journal of Psychiatry , Volume 118 , Issue 544 , March 1971 , pp. 301 - 304
Copyright
Copyright © Royal College of Psychiatrists, 1971 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Beck, A. T. (1967). Depression: Clinical, Experimental, and Theoretical Aspects. New York, p. 304.Google Scholar
Beresford Davies, E. (1963). ‘Combining the antidepressant drugs.’ Lancet, ii, 781–2.Google Scholar
Dally, P. (1967). Chemotherapy of Psychiatric Disorders London, pp. 52–4.Google Scholar
Dewhurst, W. G. (1968). ‘New theory of cerebral amine function and its clinical application.’ Nature, 218, 1130–33.Google Scholar
Gander, D. R. (1965). ‘Treatment of depressive illnesses with combined antidepressants.’ Lancet, ii, 107.Google Scholar
Gander, D. R. (1967). ‘The clinical value of monoamine oxidase inhibitors and tricyclic antidepressants in combination.’ In Proceedings of the First International Symposium on Antidepressant Drugs, (ed. Garattini, and Dukes, .) New York. pp. 336–43.Google Scholar
Horwitz, W. A. (1968). ‘Physiologic responses as prognostic guides in the use of antidepressant drugs.’ American Journal of Psychiatry. 125, 60–8.CrossRefGoogle ScholarPubMed
Lancet (1965). Leading Article. ‘Combining the antidepressant drugs.’ ii 2, 118.Google Scholar
Lancet (1968). Leading Article. ‘Amines, alerting and affect.’ i, 1237–38.Google Scholar
Malitz, S. (1966). ‘Drug therapy: Antidepressants.’ In American Handbook of Psychiatry, (ed. Arieti, .) New York, 3, 493.Google Scholar
Pare, C. M. B. (1965). ‘Treatment of depression.’ Lancet, i, 923–5.Google Scholar
Sargant, W. (1963). ‘Combining the antidepressant drugs.’ Lancet, ii, 634–5 and 1062.Google Scholar
Schildkraut, J. J. (1965). ‘The catecholamine hypothesis of affective disorders: a review of supporting evidence.’ American Journal of Psychiatry, 122, 509–22.Google Scholar
Shepherd, M., Lader, M., and Rodnight, R. (1968). Clinical Psychopharmacology: London, p. 140.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.